Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet Our Editorial Board Member free to download

Volume:21   Issue: 14
Pp: 1395-1395
S. Vetrano
DOI: 10.2174/138945012114200925101830
Published on: 20 October, 2020

Inflammatory Bowel Disease – From Bench to Bedside free to download

Volume:21   Issue: 14
Pp: 1396-1396
Jakub Fichna
DOI: 10.2174/138945012114200925102104
Published on: 20 October, 2020

Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer

Volume:21   Issue: 14
Pp: 1397-1404
Adrian Bartoszek, Jakub Fichna, Aleksandra Tarasiuk, Agata Binienda, Adam Fabisiak, Julia B. Krajewska, Paula Mosińska, Karolina Niewinna and Maciej Salaga*
DOI: 10.2174/1389450120666191112141901
Published on: 20 October, 2020

The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy

Volume:21   Issue: 14
Pp: 1405-1416
Agata Binienda, Sylwia Ziolkowska, Ingvild H. Hauge and Maciej Salaga*
DOI: 10.2174/1389450121666200504074922
Published on: 20 October, 2020

Nutritional Support and Probiotics as a Potential Treatment of IBD

Volume:21   Issue: 14
Pp: 1417-1427
Aleksandra Tarasiuk and Guido Eibl*
DOI: 10.2174/1389450121666200504075519
Published on: 20 October, 2020

Targeting Enteric Neurons and Plexitis for the Management of Inflammatory Bowel Disease

Volume:21   Issue: 14
Pp: 1428-1439
Rhian Stavely, Raquel Abalo and Kulmira Nurgali*
DOI: 10.2174/1389450121666200516173242
Published on: 20 October, 2020

Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges

Volume:21   Issue: 14
Pp: 1440-1447
Hubert Zatorski and Radislav Nakov*
DOI: 10.2174/1389450121666200602125507
Published on: 20 October, 2020

Exosomes in Inflammatory Bowel Disease: What Have We Learned So Far?

Volume:21   Issue: 14
Pp: 1448-1455
Haichao Wang, Chen Ye, Yaling Wu, Pengyu Yang, Chunqiu Chen, Zhanju Liu and Xiaolei Wang*
DOI: 10.2174/1389450121666200428102330
Published on: 20 October, 2020

Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products

Volume:21   Issue: 14
Pp: 1456-1462
Adam Makaro, Jakub Fichna and Marcin Włodarczyk*
DOI: 10.2174/1389450121666200727105218
Published on: 20 October, 2020

Immunotherapy and Radiation Therapy in Renal Cell Carcinoma

Volume:21   Issue: 14
Pp: 1463-1475
Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi and Francesco Massari*
DOI: 10.2174/1389450121666200311121540
Published on: 20 October, 2020

Antimicrobial Terpenoids as a Potential Substitute in Overcoming Antimicrobial Resistance

Volume:21   Issue: 14
Pp: 1476-1494
Aditi Sharma, Avadh Biharee, Amit Kumar and Vikas Jaitak*
DOI: 10.2174/1389450121666200520103427
Published on: 20 October, 2020

Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology

Volume:21   Issue: 14
Pp: 1495-1510
Malwina Lachowicz*, Andrzej Stańczak and Michał Kołodziejczyk
DOI: 10.2174/1389450121666200615150039
Published on: 20 October, 2020